News
Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.
Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump administration's word on ...
16h
Pharmaceutical Technology on MSNCan pharma tariffs “Make America Manufacture Again”?Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.
Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...
Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on prescription drug imports.
The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, the regulator said on Friday, making the device the first of its kind to detect ...
Business leaders from major Hoosier companies say they are trying to navigate the uncertain trade environment created by ...
Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
President Trump recently warned big drugmakers that ... the president warned that a "tariff wall" is coming. Although AbbVie, Eli Lilly, and Johnson & Johnson manufacture many of their products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results